A white paper for rejuvenation therapies and blueprint for clock.bio
mark-kotter.medium.com
Age is the common risk factor for a diverse set of diseases that become the cause of our death. clock.bio seeks to increase health span by developing pharmacological modulators for biological age…
This is an automated archive made by the Lemmit Bot.

The original was posted on /r/singularity by /u/rationalkat on 2024-10-10 11:19:05+00:00.

Original Title: Mark Kotter (clock.bio): “We believe the field is ready for disruptive innovation and aggressive pursuit of a vision to extend healthspan by 20 years based on biomarkers of ageing in a Phase 3 trial by the end of this decade.”